Clinical Trial Update: Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China

View source ↗

Summary

A completed clinical trial in China evaluated risk stratification of patients using a lung cancer biomarker panel. The update does not indicate any drug interve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Bai Chunxue | Conditions: Lung Neoplasms | Status: COMPLETED